Cosmos Insurance Pcl (0E1C) Noticias

Just Got me a few more shares. Thank you to who ever sold me there shares at this great price.

STRH .0166 news fwiw

RS means dip before split, and afterwards. Ouch.

Closed out my short from $7.57. Done trading for the day.

Adam,

It's unheard of to have earnings per share greater than the stock price. If that's the case we won't need any help.The price will take care of itself.
All positions in this ticker will make money. This is shaping up as a real company with fundamentally sound management(K

$VVPR: If the deal consumates based on $120Milly Valuations

My min guess is $9


But hard to say........ 1st day action after the news made the Shareprice gyrations look a lil suspect.

Still... its channeling a higher trend band

You mean the day everyone that’s not an accelerated is supposed to file their 10k?

Signal has been suspected as an unsecured site there is a link between them and NPR . That’s why MONI should promote their secure communication product.

SAG: $ break after PM low of .85

Wow straight down

Anyone with a clue as to why MMs are walking this down?

LXRX RS in June unless they can get it together before then. Doubt it.

Hope all is well out there!

TNON had a day, and then as usual, dilution @ $2. MULN caught my eye yesterday on volume, made about a .30 swing.

Laughable

Agree sir - slow and stready move to 30 so we don't expose our flanks is perfect for next few weeks/months of boom time.
Precious metals co time to make new highs and will help raise the tide RITE is riding 

Watts,

I have STAFF for that!

Tomcat

Goldbery has now retracted his story and said he was not listing to "war Plans" on the call. Goldberg is a traitor to America for running to his key board and telling the public he was listing to secret war plans ...the word here is SECRET
he should be prosecuted and jailed for publishing se

More lies

I'm glad that MK is on your mind though

Why do you think they don't have a pipeline. They spend 10% on R&D.
Just this month they had FDA accept 2 Denosumab Biosimilars for review.
The IQVIA® for the 12 months ended December 2024 for those two products just accepted for review was approximately $5.0 billion.

I do.

You are hilarious, captain 🤣 😂 😆

No not asleep...."Any Day" is just that...

And, in the interim, there is a possibility, imo, for CDF funding.

Contemplating on whether to pick up some more shares at .0047...need to transfer some cash though...with this delay I feel some news is definitely coming...by mid-April for sure if not sooner... this type of delay has never happened on posting a quarterly (I think) ... I realize Venkat is out of the